Resverlogix Announces Voting Results From The 2017 Annual Meeting Of Shareholders
December 12, 2017 20:08 ET
|
Resverlogix Corp
CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) announced today that, at its annual meeting of shareholders held on December 12,...
Nature’s Recent Scientific Reports Publication Describes How Apabetalone May Be a Powerful Agent Against HIV-1
December 12, 2017 07:30 ET
|
Resverlogix Corp
CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that a recent Nature Scientific Reports has published a 12 page...
Resverlogix Repays $68.8 Million Loan
December 06, 2017 19:16 ET
|
Resverlogix Corp
CALGARY, Alberta, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has repaid, in full, its CAD$68.8 million Loan (the “Loan”)....
Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink
December 04, 2017 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has closed its previously announced private placement of...
Resverlogix Announces Participation in Upcoming Conferences
November 02, 2017 08:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) is pleased to announce the Company’s participation in the following upcoming industry...
Resverlogix Announces Fifth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone
November 01, 2017 08:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announced that the independent Data and Safety Monitoring Board (DSMB) for the...
Resverlogix Announces Right of First Refusal Agreement with Hepalink USA Inc.
October 24, 2017 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced that it has entered into a Right of First Refusal Agreement (the...
Resverlogix Announces $87 Million Private Placement with Shenzhen Hepalink
October 13, 2017 09:27 ET
|
Resverlogix Corp
CALGARY, Alberta, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced a private placement of 60,416,667 equity units to Shenzhen Hepalink...
Resverlogix Announces Annual and Special Meeting of Shareholders
October 02, 2017 18:19 ET
|
Resverlogix Corp
CALGARY, Alberta, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announced today that its Annual and Special Meeting of Shareholders (the “Meeting”)...